MGTX MeiraGTx Holdings plc
Price (delayed)
$6.36
Market cap
$501.52M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.12
Enterprise value
$480.65M
MeiraGTx is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in
Highlights
The revenue has soared by 139% QoQ and by 137% YoY
MeiraGTx Holdings's debt has decreased by 5% YoY and by 2.2% QoQ
The gross margin has soared by 104% from the previous quarter but it has plunged by 72% YoY
The company's net income has shrunk by 76% YoY and by 68% QoQ
MGTX's EPS has dropped by 75% since the previous quarter and by 42% year-on-year
Key stats
What are the main financial stats of MGTX
Market
Valuations
Earnings
Shares outstanding
78.85M
Market cap
$501.52M
Enterprise value
$480.65M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.33
Price to sales (P/S)
13.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.44
Revenue
$33.28M
Gross profit
$9.49M
Operating income
-$164.21M
Net income
-$147.79M
EBIT
-$134.52M
EBITDA
-$121.69M
Free cash flow
-$81.02M
Per share
Balance sheet
Liquidity
EPS
-$2.12
EPS diluted
-$2.12
Free cash flow per share
-$1.16
Book value per share
$0.87
Revenue per share
$0.48
TBVPS
$3.85
Total assets
$269.75M
Total liabilities
$201.92M
Debt
$84.8M
Equity
$67.83M
Working capital
$62.74M
Debt to equity
1.25
Current ratio
2.03
Quick ratio
1.75
Net debt/EBITDA
0.17
Margins
Efficiency
Dividend
EBITDA margin
-365.7%
Gross margin
28.5%
Net margin
-444.1%
Operating margin
-493.4%
Return on assets
-51.6%
Return on equity
-161.8%
Return on invested capital
-65.5%
Return on capital employed
-64.4%
Return on sales
-404.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MGTX stock price
How has the MeiraGTx Holdings stock price performed over time
Intraday
3.25%
1 week
-12.03%
1 month
-10.8%
1 year
15.01%
YTD
4.43%
QTD
-6.19%
Financial performance
How have MeiraGTx Holdings's revenue and profit performed over time
Revenue
$33.28M
Gross profit
$9.49M
Operating income
-$164.21M
Net income
-$147.79M
Gross margin
28.5%
Net margin
-444.1%
The revenue has soared by 139% QoQ and by 137% YoY
The gross margin has soared by 104% from the previous quarter but it has plunged by 72% YoY
The company's net income has shrunk by 76% YoY and by 68% QoQ
The operating margin has surged by 61% since the previous quarter and by 50% year-on-year
Growth
What is MeiraGTx Holdings's growth rate over time
Valuation
What is MeiraGTx Holdings stock price valuation
P/E
N/A
P/B
7.33
P/S
13.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.44
MGTX's EPS has dropped by 75% since the previous quarter and by 42% year-on-year
The stock's price to book (P/B) is 115% more than its 5-year quarterly average of 3.3 and 73% more than its last 4 quarters average of 4.1
MGTX's equity has plunged by 51% YoY and by 29% from the previous quarter
The revenue has soared by 139% QoQ and by 137% YoY
MGTX's price to sales (P/S) is 53% lower than its 5-year quarterly average of 27.6 and 49% lower than its last 4 quarters average of 25.4
Efficiency
How efficient is MeiraGTx Holdings business performance
MeiraGTx Holdings's return on equity has shrunk by 114% YoY and by 100% QoQ
The ROIC has shrunk by 111% YoY and by 86% QoQ
MGTX's return on assets has dropped by 83% year-on-year and by 76% since the previous quarter
MGTX's ROS is up by 25% since the previous quarter and by 20% year-on-year
Dividends
What is MGTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MGTX.
Financial health
How did MeiraGTx Holdings financials performed over time
MeiraGTx Holdings's total assets is 34% higher than its total liabilities
The quick ratio has contracted by 19% from the previous quarter and by 17% YoY
MeiraGTx Holdings's total assets has decreased by 17% YoY and by 10% QoQ
MeiraGTx Holdings's debt is 25% higher than its equity
The company's debt to equity has surged by 92% YoY and by 37% QoQ
MGTX's equity has plunged by 51% YoY and by 29% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.